Frontlight ResearchEarly access
Polycystic kidney disease trials, also abroad
47 open Polycystic kidney disease trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| United States | 21 |
| Italy | 6 |
| Germany | 5 |
| Belgium | 4 |
| China | 4 |
| All other countries |
The same trial often runs in several countries
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) has 1 site in United Kingdom and runs in 6 countries. If a site near you is full, another one may still take people.
See A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) in all 6 countries